1. Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance
   Tahsin Nairuz et al, 2023, Stem Cell Reviews and Reports CrossRef
2. Targeting EZH2 Promotes Chemosensitivity of BCL-2 Inhibitor through Suppressing PI3K and c-KIT Signaling in Acute Myeloid Leukemia
   Chan Yang et al, 2022, International Journal of Molecular Sciences CrossRef
3. Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial–Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis
   Ling Ding et al, 2022, International Journal of Molecular Sciences CrossRef
4. Carcinocythemia: A rare entity becoming more common? A 3‐year, single institution series of seven cases and literature review
   Shira Ronen et al, 2019, International Journal of Laboratory Hematology CrossRef
5. MiR-222-3p Promotes Cell Proliferation and Inhibits Apoptosis by Targeting PUMA (BBC3) in Non-Small Cell Lung Cancer
   Weijun Chen et al, 2020, Technology in Cancer Research & Treatment CrossRef
6. Cancer Stem Cells and the Development of Cancer
   Nehal I. Ghoneim et al, 2020, Regenerative Medicine and Stem Cell Biology CrossRef
7. NOTCH1- and CD117-positive stem cells in human endometrium and their implications for successful implantation
   Margarita Ruseva et al, 2023, F&S Science CrossRef
8. Design, synthesis and anti-cancer activity of pyrrole-imidazole polyamides through target-downregulation of c-kit gene expression
   Mi Zhang et al, 2020, European Journal of Medicinal Chemistry CrossRef
9. Regulating POLR3G by MicroRNA-26a-5p as a promising therapeutic target of lung cancer stemness and chemosensitivity
   Chang Ryul Park et al, 2023, Non-coding RNA Research CrossRef
10. CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance
    Brittni Foster et al, 2018, Biomedicines CrossRef
11. Routine flow cytometry approach for the evaluation of solid tumor neoplasms and immune cells in minimally invasive samples
    Covadonga Quirós‐Caso et al, 2022, Cytometry Part B: Clinical Cytometry CrossRef
12. A novel anti‐c‐Kit antibody–drug conjugate to treat wild‐type and activating‐mutant c‐Kit‐positive tumors
    Jin‐Ock Kim et al, 2022, Molecular Oncology CrossRef
13. c-kit2 G-quadruplex stabilized via a covalent probe: exploring G-quartet asymmetry
    Kateřina Peterková et al, 2021, Nucleic Acids Research CrossRef
14. The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
    Anaïs Chauvin et al, 2018, Clinical Proteomics CrossRef
15. Protein Cancer Biomarkers
    Sarath S. Joseph et al, 2023, Current Cancer Biomarkers CrossRef
16. The key roles of cancer stem cell-derived extracellular vesicles
    Chaoyue Su et al, 2021, Signal Transduction and Targeted Therapy CrossRef
17. CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance
    Koran S. Harris et al, 2021, Scientific Reports CrossRef
18. Evaluation of and Current Trends in the Management of Gastrointestinal Stromal Tumors: A Systematic Review
    Hadia Arzoun et al, 2022, Cureus CrossRef
19. Clinical and Prognostic Significance of CD117 in Non-Small Cell Lung Cancer: A Systemic Meta-Analysis
    Ying Su et al, 2021, Pathobiology CrossRef